Congratulations to Professor Andrew Goodman on his election into the American Academy of Microbiology!
In February, the American Academy of Microbiology (Academy) elected 65 new Fellows to the Class of 2022. Fellows of the American Academy of Microbiology, an honorific leadership group and a think tank within the ASM, are elected annually through a highly selective, peer-review process, based on their records of scientific achievement and original contributions that have advanced microbiology. The Academy received 130 nominations this year and elected 65 into the 2022 Fellowship Class.Source: American Society for Microbiology
How plants ward off a dangerous world of pathogens
The world’s plants, immobile and rooted in soil which contains potentially lethal micro-organisms, face a constant threat from invading pathogens. In recent years, however, scientists have discovered that plant species employ sophisticated immune strategies that differ from —but also shares similarities with — the ways humans combat infections.Source: Yale News
Gut check: Yale researchers describe role of bacteria in drug response
Yale researchers identified human gut microbes that metabolize over 150 therapeutic drugs, a finding that highlights the role bacteria play in determining how well individuals respond to medications, they report June 3 in the journal Nature.
Hinchcliff is New Director of Yale Scleroderma Program
Monique Hinchcliff, MD, MS, was named director of the Yale Scleroderma Program. Hinchcliff leads an established multidisciplinary team of expert physician-scientists with an interest and expertise in systemic sclerosis, also called scleroderma.
Microbiome could be culprit when good drugs do harm
People sometimes suffer toxic side effects from drugs that help many others. Yale scientists have identified a surprising explanation — the gut microbiome. The research, published Feb. 8 in the journal Science, describes how bacteria in the gut can transform three drugs into harmful compounds. “If we can understand the microbiome’s contributions to drug metabolism, we can decide which drugs to give to patients or even alter the microbiome so patients have a better response,” said co-lead author Michael Zimmermann, postdoctoral fellow in the lab of senior author Andrew Goodman in the Department of Microbial Pathogenesis and the Microbial Sciences Institute.
Innovative way to block HIV runs into a roadblock
A Yale team led by Pradeep Uchil and Walther Mothes found that taking aim at a promising molecular target can combat the spread of retroviruses that can cause blood cancer and AIDS — but at the risk of leaving the host vulnerable to infections by other viral pathogens.